泽璟制药-U(688266)每日收评(04-01)

Group 1 - The stock of Zejing Pharmaceutical (U688266) has a comprehensive score of 73.92, indicating a strong performance [1] - The main cost analysis shows that the current main cost is 106.70 yuan, with a 5-day cost of 98.01 yuan, a 20-day cost of 92.27 yuan, and a 60-day cost of 75.63 yuan [1] - There have been no instances of the stock hitting the upper or lower limits in the past year [1] Group 2 - The technical analysis indicates a short-term resistance level at 99.74 yuan and a support level at 86.68 yuan, while the mid-term resistance is also at 99.74 yuan with a support level at 85.63 yuan [2] - The stock price has broken through the short-term resistance level, suggesting potential strength in the short term, and a break through the mid-term resistance could indicate strength in the medium term [2] - The K-line pattern shows a "Red Three Soldiers" formation, indicating a possible bottoming and rebound [2] Group 3 - On April 1, 2025, the net inflow of main funds was 84.50 million yuan, accounting for 15% of the total transaction volume [2] - The net inflow from large orders was 36.91 million yuan, while the net inflow from super large orders was 47.59 million yuan [2] - The stock is associated with sectors such as chemical pharmaceuticals (4.36%), monoclonal antibodies (4.73%), and immunotherapy (4.14%) [2]